Rafinlar

Rafinlar uses and dosage

Rafinlar (Dabrafenib), generic Tafinlar is a prescription medicine used to treat skin cancer (melanoma). It is also used to treat thyroid cancer and a type of lung cancer (non-small cell lung cancer-NSCLC). Rafinlar manufactured by Novartis Pharma Ltd. In India. Dabrafenib has to take orally usually twice daily about 12 hours apart on an empty stomach (at least 1 hour before or 2 hours after meals)

Rafinlar side effects

The most common adverse reactions of DABRAFENIB are: Hair loss, thickening of the outer layers of the skin, headache, swelling /peeling of feet/ hands.

Originator brand

TAFINLAR by NOVARTIS

Made by

Novartis Pharma

This information is provided for reference only and is not medical advice. Always consult a qualified healthcare professional.